Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
On Demand Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
On Demand Therapeutics

On Demand Therapeutics

Series A

On Demand Therapeutics develops and distributes medical instruments for drug therapies and retinal diseases in the US.

HQ
Tyngsborough, MA, US
Founded
2008
Overview
Compare
Fundraising
Employees

On Demand Therapeutics develops and distributes medical instruments focused on drug therapies and retinal diseases. Their core mission is to enhance patient care through innovative implantable devices. The company primarily serves patients in the United States, aiming to improve treatment outcomes in the medical field.

Key achievements include the successful development and distribution of cutting-edge implantable devices that have positively impacted patient care. Their innovative solutions have garnered attention within the medical community, contributing to advancements in drug therapy and retinal disease treatment.

On Demand Therapeutics - Similar Companies

ONL Therapeutics logo

ONL Therapeutics

Stealth Therapeutics logo

Stealth Therapeutics

OcuMedic logo

OcuMedic

Iscience Surgical logo

Iscience Surgical

Ocudyne logo

Ocudyne

ocudyne.com

Replenish logo

Replenish

EyeCyte logo

EyeCyte

eyecyte.com

Corinthian Ophthalmic logo

Corinthian Ophthalmic

Osseon Therapeutics logo

Osseon Therapeutics

Oraya Therapeutics logo

Oraya Therapeutics

Amorphex Therapeutics logo

Amorphex Therapeutics

amorphexusa.com

Ontogen Medtech logo

Ontogen Medtech

ontogenmedtech.com

Aero Therapeutics logo

Aero Therapeutics

Talima Therapeutics logo

Talima Therapeutics

talima.com

TherOptix logo

TherOptix

On Demand Therapeutics - Quick Facts

Who are On Demand Therapeutics' competitors?

Companies similar to On Demand Therapeutics include ONL Therapeutics, Stealth Therapeutics, OcuMedic and Iscience Surgical.

When was On Demand Therapeutics founded?

On Demand Therapeutics was founded in 2008.

Where is On Demand Therapeutics' headquarters located?

On Demand Therapeutics' headquarters is located in Tyngsborough, MA, US.

When was On Demand Therapeutics' last funding round?

On Demand Therapeutics' most recent funding round was for $2.6M (USD) in June 2011.

How much has On Demand Therapeutics raised to-date?

As of Jun 17, 2011, On Demand Therapeutics has raised a total of $3.8M (USD).

How many employees does On Demand Therapeutics have?

On Demand Therapeutics has 5 employees as of Feb 5, 2024.

On Demand Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Instruments
Tags
  • Hardware
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research